Loading...
Pharmacologic Therapies for Idiopathic Pulmonary Fibrosis, Past and Future
Idiopathic pulmonary fibrosis (IPF) is a severe, progressive fibrotic disease of the lung of unknown etiology that affects approximately 150,000 patients in the United States. It carries a median survival of two to three years, but clinical course can vary markedly from patient to patient. There has...
Saved in:
| Published in: | Ann Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4638420/ https://ncbi.nlm.nih.gov/pubmed/25613169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07853890.2014.991751 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|